HIV Drug Buyers Want Gilead Product Switch Claims Revived

Insurers and benefit plans are asking the Ninth Circuit to revive a chunk of their antitrust case against Gilead, arguing their claims that Gilead delayed generic competition to its HIV drugs...

Already a subscriber? Click here to view full article